ABSTRACT
Objective To evaluate the efficacy and safety of Prostant in the treatment of chronic prostatitis. Methods A randomized, double-blind, positive drug-controlled clinical trial method was applied in the study. Through clinical symptoms, signs and expressed prostate secretion (EPS) examination, 80 patients with prostatitis were recruited and randomized into a trial group (60 cases) and a control group (20 cases). The trial group was treated with Prostant, and the control group was treated with wild chrysanthemum suppository. After screening, treatment and follow-up, in the trial group and the control group, the observation on clinical efficacy and safety were evaluated, such as the clinical symptoms, signs, EPS examination, the national institute health-chronic prostatits symptom index (NIH-CPSI) and the blood routine, urine routine, stool routine, the function of liver and kindney, electrocardiograph examination and the side effects. Results After 4-week treatment, the total effective rate was 74.14% in the trial group and 40.0% in the control group, the efficacy of Prostant was superior to that of wild chrysanthemum suppository (P =0.006). There was significant difference in clinical symptoms and NIH-CPSI between pre-treatment and post-treatment in the trial group and the control group (P
ABSTRACT
Objective To evaluate the efficacy and safety of Prostant TM and the patients’ compliance with the treatment of chronic prostatitis of different types. Methods A multi-central,randomized,double-blind,placebo-controlled clinical trial was conducted between June 2002 and December 2002.A total of 125 patients who had been diagnosed as chronic prostatitis and classified according to NIH classification system for prostatitis were divided into two groups: the trial group treated with Prostant TM anally one pill per night for 30 days and the control group given placebo in the same way.The efficacy was evaluated by the NIH chronic prostatitis symptom index (NIH-CPSI) and the WBC count in EPS after the treatment. Results Based on leukocyte and culture results,124 evaluable patients were stratified,with 48 cases of categories Ⅱ(38.7%),45 cases of Ⅲa(36.3%) and 31 cases of Ⅲb(25.0%)with chronic prostatitis.The overall NIH-CPSI scores were averagely reduced by 10.37 points in trial group and 6.65 in control group,and the symptom scores were averagely reduced by 7.34 in trial group and 4.72 in controll group,compared with pre-treatment.Significant differences of reduction were found between the two groups(P
ABSTRACT
Objective To evaluate the efficacy and safety of Prostant TM in the treatment of chronic prostatitis. Methods A multi center, randomized, double blinded, placebo controlled trial was carried out during March 2001 and May 2001. 72 cases of patients who had been diagnosed as chronic prostatitis were separated into tow groups: 36 cases in the trial group treated with Prostant TM and the other 36 cases in the controlled group using placebo. The efficacy was evaluated by the WBC in EPS and NIH Chronic Prostatitis Symptom Index after a one month follow up. The efficacy of the therapy was divided into four levels:cure,the symptom index score being reduced over 90%, and the number of WBC in the EPS less than 10/HP; effective, the symptom index score being reduced 60%～89% and the number of WBC in the EPS lowered over 50% or less than 15/HP;improved,the symptom index score being reduced 30%～59% and the number of WBC in the EPS lowered over 25%; no effect, the symptom index score being reduced less than 30% or the number of WBC in the EPS lowered no more than 25%. Results All but two cases had completed the follow up.One case (2.8%) was completely cured,remarkable effective in 7 cases (20.0%) of the trial group;and improred in 16 cases (45.7%).Only 2 cases (5.7%)seemed effective and 8 cases (22.8%) improved in the controlled group. The efficacy showed significant difference between these two groups ( P
ABSTRACT
Objective: To investigate the effect of cognitive intervention on the therapy to Chronic prostatitis(CP) following Sexually Transmitted Diseases(STD). Methods: 84 patients were divided into two groups, as control group(n=42) in which prostant was locally used and the intervention group(n=42) which received cognitive Intervention therapy based on the locally using prostant. After a month, the therapy effect was evaluated. Results: Compared with control group, the subjective syndrome in intervention group was improved much more apparent receiving therapy one month later(P 0.05). Conclusion: Cognitive intervention is an effective method to improve the subjective syndrome of CP following STD; so a clinical medicine should study psychology.
ABSTRACT
0.05).CONCLUSION:Scheme B has better compliance and is more economical as compared with scheme A.